The company backed its application with results from the Phase II/III QUILT-3.032 study, in which maintenance treatment with Anktiva plus BCG elicited a complete response rate of 62%, with duration of response exceeding 47 months at the November 2023 cut-off
The peptide safety guide covers sterile technique in comprehensive detail
Popular with our patients seeking metabolic optimization, longevity support, and performance enhancement
The peptide modulates pro-inflammatory cytokines (TNF-alpha and IL-6), signaling proteins that drive inflammatory responses in damaged tissue
Common requirements include ISO certifications (e.g., ISO 13485 for quality management systems, ISO 7886-1 for sterile hypodermic syringes), CE marking for the European market, and FDA 510(k) clearance or approval for the US market